Opana Buyers' $145M Deal With $50M In Atty Fees Gets Final OK
The attorneys who secured a $145 million settlement for direct purchasers of Endo Pharmaceuticals's Opana ER who said they overpaid generic-drug maker Impax Labs for the prescription painkiller because of a pay-for-delay deal will...To view the full article, register now.
Already a subscriber? Click here to view full article